Active Life Expectancy Estimation
Also known as: ALE, Disability-Free Years Expectancy, Independent Life Expectancy, Active vs Dependent Life Years
Active life expectancy (ALE) estimates how many of an older person's remaining years are expected to be lived in an active, independent state — free of disability in basic activities of daily living — as opposed to a dependent state requiring help. Introduced by Sidney Katz, Laurence Branch, and colleagues in 1983 in the New England Journal of Medicine, it answered a question that ordinary life expectancy cannot: not just how long people live, but how much of that life is lived in good functional health. The method combines age-specific mortality with the prevalence or transitions of ADL disability within a life-table framework, partitioning total remaining life into active and dependent components that sum to overall life expectancy. Katz and colleagues showed, using data from older adults in Massachusetts, that active life expectancy declines faster than total life expectancy with age and differs across groups. The concept reframed the goal of aging policy from merely extending lifespan to extending the active, independent portion of it. It launched the broader field of health expectancy measures and remains foundational to studying the compression or expansion of late-life morbidity.
Key highlights
- Distinguishes the quality of survival by separating active, independent years from dependent years, going beyond plain life expectancy.
- Components sum to total life expectancy, giving an interpretable and additive partition of remaining life.
- Built on standard, transparent life-table methods that demographers and health agencies can readily apply.
- Enables comparison of healthy aging across groups and over time, informing the compression-of-morbidity debate and care planning.
Intuition
This section is available to Pro members. Upgrade to Pro
How it works
This section is available to Pro members. Upgrade to Pro
When to use it
Use active life expectancy estimation when the question is not simply how long people live but how many of their remaining years are spent independent versus needing care, and you have age-specific mortality together with data on ADL disability prevalence or transitions. It is appropriate for monitoring population health, evaluating whether late-life morbidity is being compressed or expanded, comparing healthy aging across countries or social groups, and informing long-term care and pension planning. The prevalence-based (Sullivan-style) computation is suitable for cross-sectional disability data and is widely used for routine indicators, while the multistate (increment-decrement) form is preferable when longitudinal data on transitions between active and dependent states are available and recovery is important. It is less suitable where disability is measured inconsistently across time or place, since active life expectancy is only as comparable as its underlying disability definition, and care is needed because prevalence-based estimates reflect past transitions rather than current dynamics.
Strengths & limitations
- Distinguishes the quality of survival by separating active, independent years from dependent years, going beyond plain life expectancy.
- Components sum to total life expectancy, giving an interpretable and additive partition of remaining life.
- Built on standard, transparent life-table methods that demographers and health agencies can readily apply.
- Enables comparison of healthy aging across groups and over time, informing the compression-of-morbidity debate and care planning.
- Comparability depends entirely on a consistent definition and measurement of ADL disability across populations and periods.
- The prevalence-based (Sullivan) form reflects historical transitions, not current incidence, and can lag real change.
- Capturing recovery from dependency back to independence requires longitudinal transition data and the more demanding multistate model.
- Estimates are sensitive to the disability threshold chosen, so different ADL cutoffs yield different active-year counts.
Common pitfalls
This section is available to Pro members. Upgrade to Pro
Applications
This section is available to Pro members. Upgrade to Pro
Frequently asked
How does active life expectancy differ from ordinary life expectancy?
Ordinary life expectancy estimates the total number of years a person can expect to live, regardless of health. Active life expectancy splits those remaining years into an active, independent portion (free of disability in basic activities of daily living) and a dependent portion, with the two summing to total life expectancy. Katz and colleagues introduced it precisely to capture the quality of survival, showing that the active portion declines faster with age than the total, so older groups spend a larger share of life dependent.
Is active life expectancy the same as the Sullivan method?
They are closely related but not identical. The Sullivan method is a specific, prevalence-based way to compute a health expectancy by applying age-specific disability prevalence to life-table person-years, and it can be used to estimate active life expectancy. Katz's active life expectancy is the broader concept of partitioning remaining life into active and dependent years, which can be estimated either by the Sullivan prevalence approach or by multistate (increment-decrement) life tables that use transitions between states and can represent recovery.
Can people move from dependent back to active in this framework?
In the prevalence-based Sullivan computation, no transitions are modelled explicitly; only the net prevalence of disability by age is used, so recovery is captured only implicitly through lower prevalence. To represent recovery directly, the multistate or increment-decrement life table is used, which models age-specific probabilities of moving among active, dependent, and dead states, including regaining independence. This richer approach requires longitudinal data on transitions but gives a more dynamic and realistic picture of late-life functional trajectories.
Sources
- 1.Katz, S., Branch, L. G., Branson, M. H., Papsidero, J. A., Beck, J. C., & Greer, D. S. (1983). Active life expectancy. New England Journal of Medicine, 309(20), 1218-1224.
You have read it. What now?
Cite this page
ScholarGate. (2026, June 23). Active Life Expectancy Estimation. ScholarGate. https://scholargate.app/social-gerontology/active-life-expectancy